Publication & Citation Trends
Publications
0 total
A phase II trial of reirradiation combined with pembrolizumab in patients with locoregional inoperable recurrence or second primary squamous cell carcinoma of the head and neck (HNSCC).
Cited by 0
Semantic Scholar
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery
Cited by 1
Semantic Scholar
Analysis of pathological complete response rates with paclitaxel-based regimens in trimodality therapy for esophageal cancer. OA
Cited by 8
Semantic Scholar
The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.
Cited by 31
Semantic Scholar
Research Topics
Head and Neck Cancer Studies
(35)
Esophageal Cancer Research and Treatment
(32)
Lung Cancer Diagnosis and Treatment
(26)
Lung Cancer Treatments and Mutations
(24)
Gastric Cancer Management and Outcomes
(22)
Affiliations
University of Maryland, Baltimore
Brigham and Women's Hospital
University of Maryland Medical Center
Cleveland Clinic
University Health Network